Spine
InVivo shares soar on spinal cord study update
Baxano Surgical files for bankruptcy, CFO steps down
Medicrea wins FDA clearance for patient-specific spinal rod
Medicrea said it won 510(k) clearance from the FDA for its UNiD device, billed as the world’s 1st patient-specific spinal osteosynthesis rod.
Orthofix tests Cervical-Stim for spinal fractures
Integra LifeSciences to spin out spine biz
Temporary tax hit pushes NuVasive into Q3 red
Nevro sets range for IPO of up to $106m
Nevro Corp. set the price range for its forthcoming initial public offering, which would raise $106.3 million at the high end of the range.
Menlo Park, Calif.-based Nevro plans to trade on the NASDAQ exchange under the symbol NVRO, according to a regulatory filing.
Boston Scientific wins CE Mark, FDA nod for spinal surgical leads
Medtronic’s new line of spinal implants drops
Nevro registers $100m IPO
Nevro Corp. said it plans to raise more than $100 million in an initial public offering of stock for its implantable spinal cord stimulation system to treat chronic pain.